Today is #CleanAirDay
Read our latest Editorial - Clean Air Day: breathe locally, plan globally
www.thelancet.com/journals/lan...
From @lancetrespirmed.bsky.social 🫁
The link between 60-day mortality and personalized, best-practice mechanical ventilation in patients with #AcuteRespiratoryDistressSyndrome may be stronger in those with hypoinflammatory vs hyperinflammatory ARDS.
📊 New Article available #OpenAccess
📌Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (SNaPP): an international, randomised, controlled, phase 4 trial
🔗 www.thelancet.com/journals/lan...
🌅 Check out the #SUNRISE phase 3 trial of tezepelumab in reducing OCS use in severe, OCS-dependent #asthma
🟥Efficacy and safety of tezepelumab vs placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent #asthma (SUNRISE)
tinyurl.com/6h8xtr8w
🎙️New Podcast
Andrew Bush, Heather Zar, and Fernando de Benedictis on how inhaled corticosteroids have changed the treatment of asthma
www.thelancet.com/audio-do/and...
Check out the full paper here: www.thelancet.com/journals/lan...
💡 New Spotlight: Africa's inhaler dilemma
Esther Nakkazi reports on the issues of cost, climate, and care
www.thelancet.com/journals/lan...
📰 New Correspondence: Toxic skies of war
"Environmental agencies and health organisations should address war as a dimension of increased environmental risk and hold those responsible to account for the environmental damage caused by warfare actions."
www.thelancet.com/journals/lan...
🏥 June issue of The Lancet Respiratory Medicine available online and in print now!
Check out the full issue here: www.thelancet.com/issue/S2213-...
📜 Editorial
Clean Air Day: breathe locally, plan globally
www.thelancet.com/journals/lan...
🗞️ News: 2026 #GINA report for #asthma
On May 5, 2025, the Global Initiative for Asthma published the 2026 update to their Global Strategy for Asthma Management and Prevention.
Check out the major updates here: www.thelancet.com/journals/lan...
Written by Priya Venkatesan
It's official! The SNaPP trial @anzcactn.bsky.social findings are out, published today @lancetrespirmed.bsky.social, a four year trial with principal investigator @katy-skier.bsky.social.
A “hidden pandemic” of lung complications after surgery has been highlighted by an international study led by Australian anaesthetists that has found how a newer muscle relaxant reversal drug can help...
Recent reports indicate that the burden of chronic respiratory diseases has increased
by 80% in the Middle East and Northern Africa region between 1990 and 2019,1 and air
pollution in the region, part...
In this study, tezepelumab treatment led to greater reductions from baseline in daily
oral corticosteroid dose than placebo at week 28 despite early study termination.
No safety concerns were identifi...
www.thelancet.com
When baby Sidrah Isaacs was born, she appeared well. At around 6 weeks of age, her
mother, Sasha Leigh, began to notice concerning symptoms, including a silent cough,
a weak cry, and breathing difficu...
Sugammadex reduced the incidence of postoperative pulmonary complications or death
compared with neostigmine. The risk reduction was small with atelectasis of uncertain
clinical significance being the...
Inhaled corticosteroids are the foundation of asthma therapy and now, 50 years on
from their introduction, is an appropriate time to summarise some of the key studies
that have progressed the field. W...
On May 5, 2025, the Global Initiative For Asthma (GINA) published the 2026 update
to their Global Strategy for Asthma Management and Prevention. On the same date, an
online discussion hosted by GINA p...
